Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential

Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential

As part of Oncology Research Pulse, our new thought leadership initiative designed to foster collaboration that advances cancer research, we’re partnering with Fierce Pharma to explore how just-in-time (JIT) oncology trials can accelerate research, reduce costs, and expand patient access to cutting-edge treatments. 

Learning Objectives:

1. Accelerating patient access through data-driven pre-screening and site partnerships 
2. Optimizing sponsor-site-IRB collaboration for seamless trial activation 
3. Overcoming operational hurdles with pre-negotiated agreements and standardized processes 
4. Balancing speed and quality in real-world JIT oncology trials 

Christine Senn

Senior Vice President, Site-Sponsor Innovation, Advarra